A citation-based method for searching scientific literature

Rediet Zewdu, Elnaz Mirzaei Mehrabad, Kelley Ingram, Pengshu Fang, Katherine L Gillis, Soledad A Camolotto, Grace Orstad, Alex Jones, Michelle C Mendoza, Benjamin T Spike, Eric L Snyder. Elife 2021
Times Cited: 3







List of co-cited articles
11 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


FoxA1 and FoxA2 drive gastric differentiation and suppress squamous identity in NKX2-1-negative lung cancer.
Soledad A Camolotto, Shrivatsav Pattabiraman, Timothy L Mosbruger, Alex Jones, Veronika K Belova, Grace Orstad, Mitchell Streiff, Lydia Salmond, Chris Stubben, Klaus H Kaestner,[...]. Elife 2018
23
100

Kras(G12D) and Nkx2-1 haploinsufficiency induce mucinous adenocarcinoma of the lung.
Yutaka Maeda, Tomoshi Tsuchiya, Haiping Hao, David H Tompkins, Yan Xu, Michael L Mucenski, Lingling Du, Angela R Keiser, Takuya Fukazawa, Yoshio Naomoto,[...]. J Clin Invest 2012
100
100

Nkx2-1 represses a latent gastric differentiation program in lung adenocarcinoma.
Eric L Snyder, Hideo Watanabe, Margaret Magendantz, Sebastian Hoersch, Tiffany A Chen, Diana G Wang, Denise Crowley, Charles A Whittaker, Matthew Meyerson, Shioko Kimura,[...]. Mol Cell 2013
133
100

A slow-cycling LGR5 tumour population mediates basal cell carcinoma relapse after therapy.
Adriana Sánchez-Danés, Jean-Christophe Larsimont, Mélanie Liagre, Eva Muñoz-Couselo, Gaëlle Lapouge, Audrey Brisebarre, Christine Dubois, Mariano Suppa, Vijayakumar Sukumaran, Véronique Del Marmol,[...]. Nature 2018
55
66

A cell identity switch allows residual BCC to survive Hedgehog pathway inhibition.
Brian Biehs, Gerrit J P Dijkgraaf, Robert Piskol, Bruno Alicke, Soufiane Boumahdi, Franklin Peale, Stephen E Gould, Frederic J de Sauvage. Nature 2018
50
66

Suppression of lung adenocarcinoma progression by Nkx2-1.
Monte M Winslow, Talya L Dayton, Roel G W Verhaak, Caroline Kim-Kiselak, Eric L Snyder, David M Feldser, Diana D Hubbard, Michel J DuPage, Charles A Whittaker, Sebastian Hoersch,[...]. Nature 2011
284
66


The Lineage-Defining Transcription Factors SOX2 and NKX2-1 Determine Lung Cancer Cell Fate and Shape the Tumor Immune Microenvironment.
Gurkan Mollaoglu, Alex Jones, Sarah J Wait, Anandaroop Mukhopadhyay, Sangmin Jeong, Rahul Arya, Soledad A Camolotto, Timothy L Mosbruger, Chris J Stubben, Christopher J Conley,[...]. Immunity 2018
54
66

A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors.
David Dankort, Elena Filenova, Manuel Collado, Manuel Serrano, Kirk Jones, Martin McMahon. Genes Dev 2007
339
66

MEK1/2 inhibition elicits regression of autochthonous lung tumors induced by KRASG12D or BRAFV600E.
Christy L Trejo, Joseph Juan, Silvestre Vicent, Alejandro Sweet-Cordero, Martin McMahon. Cancer Res 2012
42
66

Identification of stem cells in small intestine and colon by marker gene Lgr5.
Nick Barker, Johan H van Es, Jeroen Kuipers, Pekka Kujala, Maaike van den Born, Miranda Cozijnsen, Andrea Haegebarth, Jeroen Korving, Harry Begthel, Peter J Peters,[...]. Nature 2007
66

Dynamic regulation of Pdx1 enhancers by Foxa1 and Foxa2 is essential for pancreas development.
Nan Gao, John LeLay, Marko Z Vatamaniuk, Sebastian Rieck, Joshua R Friedman, Klaus H Kaestner. Genes Dev 2008
206
33

Defining the Identity and Dynamics of Adult Gastric Isthmus Stem Cells.
Seungmin Han, Juergen Fink, David J Jörg, Eunmin Lee, Min Kyu Yum, Lemonia Chatzeli, Sebastian R Merker, Manon Josserand, Teodora Trendafilova, Amanda Andersson-Rolf,[...]. Cell Stem Cell 2019
33
33

Understanding and targeting resistance mechanisms in NSCLC.
Julia Rotow, Trever G Bivona. Nat Rev Cancer 2017
374
33

Unique Genetic and Survival Characteristics of Invasive Mucinous Adenocarcinoma of the Lung.
Hyo Sup Shim, Mari- Kenudson, Zongli Zheng, Matthew Liebers, Yoon Jin Cha, Quan Hoang Ho, Maristela Onozato, Long Phi Le, Rebecca S Heist, A John Iafrate. J Thorac Oncol 2015
86
33

Comprehensive Integration of Single-Cell Data.
Tim Stuart, Andrew Butler, Paul Hoffman, Christoph Hafemeister, Efthymia Papalexi, William M Mauck, Yuhan Hao, Marlon Stoeckius, Peter Smibert, Rahul Satija. Cell 2019
33

edgeR: a Bioconductor package for differential expression analysis of digital gene expression data.
Mark D Robinson, Davis J McCarthy, Gordon K Smyth. Bioinformatics 2010
33


Negative Thyroid Transcription Factor 1 Expression Defines an Unfavorable Subgroup of Lung Adenocarcinomas.
Yiliang Zhang, Rui Wang, Yuan Li, Yunjian Pan, Haichuan Hu, Yang Zhang, Hang Li, Lei Shen, Yongfu Yu, Yihua Sun,[...]. J Thorac Oncol 2015
30
33

Molecular basis of Wnt activation via the DIX domain protein Ccd1.
Yi-Tong Liu, Qiong-Jie Dan, Jiawei Wang, Yingang Feng, Lei Chen, Juan Liang, Qinxi Li, Sheng-Cai Lin, Zhi-Xin Wang, Jia-Wei Wu. J Biol Chem 2011
29
33

GNAS mutations in primary mucinous and non-mucinous lung adenocarcinomas.
Lauren L Ritterhouse, Marina Vivero, Mari Mino-Kenudson, Lynette M Sholl, A John Iafrate, Valentina Nardi, Fei Dong. Mod Pathol 2017
20
33

Diminished WNT -> β-catenin -> c-MYC signaling is a barrier for malignant progression of BRAFV600E-induced lung tumors.
Joseph Juan, Teruyuki Muraguchi, Gioia Iezza, Rosalie C Sears, Martin McMahon. Genes Dev 2014
48
33

ERK1/2 phosphorylate Raptor to promote Ras-dependent activation of mTOR complex 1 (mTORC1).
Audrey Carriere, Yves Romeo, Hugo A Acosta-Jaquez, Julie Moreau, Eric Bonneil, Pierre Thibault, Diane C Fingar, Philippe P Roux. J Biol Chem 2011
158
33

Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.
E L Jackson, N Willis, K Mercer, R T Bronson, D Crowley, R Montoya, T Jacks, D A Tuveson. Genes Dev 2001
33


Efficacy of cetuximab in the treatment of Menetrier's disease.
William H Fiske, Jarred Tanksley, Ki Taek Nam, James R Goldenring, Robbert J C Slebos, Daniel C Liebler, Amir M Abtahi, Bonnie La Fleur, Gregory D Ayers, Christopher D Lind,[...]. Sci Transl Med 2009
38
33

Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway.
Eek-hoon Jho, Tong Zhang, Claire Domon, Choun-Ki Joo, Jean-Noel Freund, Frank Costantini. Mol Cell Biol 2002
33

Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity.
James Tsai, John T Lee, Weiru Wang, Jiazhong Zhang, Hanna Cho, Shumeye Mamo, Ryan Bremer, Sam Gillette, Jun Kong, Nikolas K Haass,[...]. Proc Natl Acad Sci U S A 2008
942
33

MEK inhibitors activate Wnt signalling and induce stem cell plasticity in colorectal cancer.
Tianzuo Zhan, Giulia Ambrosi, Anna Maxi Wandmacher, Benedikt Rauscher, Johannes Betge, Niklas Rindtorff, Ragna S Häussler, Isabel Hinsenkamp, Leonhard Bamberg, Bernd Hessling,[...]. Nat Commun 2019
51
33

Histologic Transformation from Adenocarcinoma to Squamous Cell Carcinoma as a Mechanism of Resistance to EGFR Inhibition.
Pavel A Levin, Melissa Mayer, Sharon Hoskin, Joseph Sailors, Dwight H Oliver, David E Gerber. J Thorac Oncol 2015
38
33

The Immune Function of Tuft Cells at Gut Mucosal Surfaces and Beyond.
Hung-An Ting, Jakob von Moltke. J Immunol 2019
43
33

Generation of primary tumors with Flp recombinase in FRT-flanked p53 mice.
Chang-Lung Lee, Everett J Moding, Xiaofang Huang, Yifan Li, Loretta Z Woodlief, Rafaela C Rodrigues, Yan Ma, David G Kirsch. Dis Model Mech 2012
43
33

Hepatocyte nuclear factor 3beta (Foxa2) is dispensable for maintaining the differentiated state of the adult hepatocyte.
N J Sund, S L Ang, S D Sackett, W Shen, N Daigle, M A Magnuson, K H Kaestner. Mol Cell Biol 2000
112
33

Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer.
Marcus Ruscetti, John P Morris, Riccardo Mezzadra, James Russell, Josef Leibold, Paul B Romesser, Janelle Simon, Amanda Kulick, Yu-Jui Ho, Myles Fennell,[...]. Cell 2020
69
33

Dabrafenib plus trametinib in patients with previously treated BRAF(V600E)-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial.
David Planchard, Benjamin Besse, Harry J M Groen, Pierre-Jean Souquet, Elisabeth Quoix, Christina S Baik, Fabrice Barlesi, Tae Min Kim, Julien Mazieres, Silvia Novello,[...]. Lancet Oncol 2016
418
33

A single-cell survey of the small intestinal epithelium.
Adam L Haber, Moshe Biton, Noga Rogel, Rebecca H Herbst, Karthik Shekhar, Christopher Smillie, Grace Burgin, Toni M Delorey, Michael R Howitt, Yarden Katz,[...]. Nature 2017
530
33

STAR: ultrafast universal RNA-seq aligner.
Alexander Dobin, Carrie A Davis, Felix Schlesinger, Jorg Drenkow, Chris Zaleski, Sonali Jha, Philippe Batut, Mark Chaisson, Thomas R Gingeras. Bioinformatics 2013
33

An aspartic proteinase expressed in the yolk sac and neonatal stomach of the mouse.
X Chen, C S Rosenfeld, R M Roberts, J A Green. Biol Reprod 2001
25
33

Tuft Cells Inhibit Pancreatic Tumorigenesis in Mice by Producing Prostaglandin D2.
Kathleen E DelGiorno, Chi-Yeh Chung, Vera Vavinskaya, H Carlo Maurer, Sammy Weiser Novak, Nikki K Lytle, Zhibo Ma, Rajshekhar R Giraddi, Dezhen Wang, Linjing Fang,[...]. Gastroenterology 2020
13
33

Discovery of (S)-1-(1-(4-Chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one (GDC-0994), an Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Inhibitor in Early Clinical Development.
James F Blake, Michael Burkard, Jocelyn Chan, Huifen Chen, Kang-Jye Chou, Dolores Diaz, Danette A Dudley, John J Gaudino, Stephen E Gould, Jonas Grina,[...]. J Med Chem 2016
69
33

A case of invasive mucinous adenocarcinoma of the lung showing stepwise progression at the primary site.
Hitomi Kawai, Masato Sugano, Noriyuki Nakano, Masafumi Muratani, Shingo Sakashita, Yukinobu Goto, Masayuki Noguchi. Lung Cancer 2019
1
100

POU2F3 is a master regulator of a tuft cell-like variant of small cell lung cancer.
Yu-Han Huang, Olaf Klingbeil, Xue-Yan He, Xiaoli S Wu, Gayatri Arun, Bin Lu, Tim D D Somerville, Joseph P Milazzo, John E Wilkinson, Osama E Demerdash,[...]. Genes Dev 2018
92
33

Wnt signaling in cancer.
T Zhan, N Rindtorff, M Boutros. Oncogene 2017
33

Sprouty-2 regulates oncogenic K-ras in lung development and tumorigenesis.
Alice T Shaw, Alexander Meissner, James A Dowdle, Denise Crowley, Margaret Magendantz, Chensi Ouyang, Tiziana Parisi, Jayaraj Rajagopal, Leah J Blank, Roderick T Bronson,[...]. Genes Dev 2007
105
33

Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer.
J Jonkers, R Meuwissen, H van der Gulden, H Peterse, M van der Valk, A Berns. Nat Genet 2001
757
33

Diffusion maps for high-dimensional single-cell analysis of differentiation data.
Laleh Haghverdi, Florian Buettner, Fabian J Theis. Bioinformatics 2015
251
33

NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combination.
Marcus Ruscetti, Josef Leibold, Matthew J Bott, Myles Fennell, Amanda Kulick, Nelson R Salgado, Chi-Chao Chen, Yu-Jui Ho, Francisco J Sanchez-Rivera, Judith Feucht,[...]. Science 2018
113
33

A signature-based method for indexing cell cycle phase distribution from microarray profiles.
Hideaki Mizuno, Yoshito Nakanishi, Nobuya Ishii, Akinori Sarai, Kunio Kitada. BMC Genomics 2009
20
33

Whole-exome sequencing identifies ADRA2A mutation in atypical familial partial lipodystrophy.
Abhimanyu Garg, Shireesha Sankella, Chao Xing, Anil K Agarwal. JCI Insight 2016
16
33

Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences.
Charlotte Soneson, Michael I Love, Mark D Robinson. F1000Res 2015
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.